A. Galat

发表

Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.

P. Pibarot, F. Tournoux, E. Teiger, 2019, Journal of the American College of Cardiology.

Prognostic value of right ventricular systolic function in cardiac amyloidosis

J. Deux, J. Dubois-Randé, L. Hittinger, 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment

E. Teiger, L. Hittinger, F. Montestruc, 2021, Journal of clinical medicine.

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis

J. Deux, J. Lefaucheur, F. Lemonnier, 2021, ESC heart failure.

Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis

J. Deux, J. Lefaucheur, E. Teiger, 2020, European journal of heart failure.

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis

J. Lefaucheur, F. Roche, E. Teiger, 2020, ESC heart failure.

Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?

J. Dubois-Randé, E. Audureau, E. Teiger, 2016, European Heart Journal.

Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival

A. Amiot, J. Deux, E. Teiger, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation

J. Deux, E. Teiger, E. Itti, 2021, Journal of clinical medicine.

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis

J. Dubois-Randé, L. Hittinger, M. Meignan, 2015, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value

J. Deux, J. Lefaucheur, E. Itti, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Tafamidis Decreases Cardiac Uptake of 99mTc-HMDP in Transthyretin Cardiac Amyloidosis.

E. Teiger, E. Itti, T. Damy, 2022, JACC. Cardiovascular imaging.

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis

J. Dubois-Randé, L. Hittinger, M. Meignan, 2015, Orphanet Journal of Rare Diseases.

Identification of prognostic markers in transthyretin and AL cardiac amyloidosis*

J. Deux, L. Hittinger, V. Planté-Bordeneuve, 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study

A. Moktefi, P. Grimbert, P. Rémy, 2022, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement

G. Derumeaux, J. Monin, T. Damy, 2019, ESC heart failure.

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement

F. Lemonnier, E. Teiger, O. Agbulut, 2021, PloS one.

Prevalence and determinants of iron deficiency in cardiac amyloidosis

E. Teiger, L. Hittinger, B. Funalot, 2022, ESC heart failure.

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis

A. Amiot, J. Lefaucheur, E. Audureau, 2023, Frontiers in Cardiovascular Medicine.

Early Phase 99Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis.

J. Dubois-Randé, L. Hittinger, M. Meignan, 2017, JACC. Cardiovascular imaging.

Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis

J. Dubois-Randé, E. Itti, V. Planté-Bordeneuve, 2018, Journal of Nuclear Cardiology.

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis

J. Dubois-Randé, E. Itti, V. Planté-Bordeneuve, 2015, Orphanet Journal of Rare Diseases.

Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis

J. Dubois-Randé, E. Itti, V. Planté-Bordeneuve, 2018, Journal of Nuclear Cardiology.

[18F]-NaF PET/CT imaging in cardiac amyloidosis

J. Garot, J. Dubois-Randé, L. Hittinger, 2016, Journal of Nuclear Cardiology.

Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis.

J. Deux, E. Teiger, L. Hittinger, 2022, Mayo Clinic proceedings.

99mTc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis

D. Attias, M. Meignan, E. Itti, 2015, Journal of Nuclear Cardiology.

Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis.

R. Carter-Storch, M. Annabi, M. Kharoubi, 2024, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

IMAGES THAT TEACH 99m Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis

D. Attias, M. Meignan, E. Itti, 2015 .